(QRX:Australian Stock Exchange Ltd)
Richard A. Paul M.D.
Former Executive Vice President of Drug Development, QRxPharma Limited
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2013
Mr. Richard A. Paul M.D has been the Chief Medical Officer and Vice President of Medical/Regulatory Affairs at SynteractHCR since April 2, 2013. Mr. Paul is providing global leadership and oversight for medical safety and regulatory affairs. He has more than 23 years of clinical research, regulatory affairs, medical safety and strategic drug development experience. Prior to joining SynteractHCR, Mr. Paul served as Executive Vice President of Drug Development at QRxPharma ...
100 Walker StreetPhone: 61 2 8404 4139
North Sydney, New South Wales 2060
Fax: 61 2 8920 0314
Board Members Memberships*There is no Board Members Memberships data available.
Universitat de Barcelona
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|